Moleculin Biotech Inc

NASDAQ:MBRX   4:00:00 PM EDT
0.96
+0.02 (+2.13%)
4:49:38 PM EDT: $0.96 0.00 (0.00%)
Products

Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066

Published: 12/01/2020 12:37 GMT
Moleculin Biotech Inc (MBRX) - Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for Wp1066.